Unibrez 150mcg Rotacap
Prescription Required
Product introduction
Unibrez 150mcg Rotacap is used for the treatment of chronic obstructive pulmonary disorder(COPD), a lung disorder in which the flow of air to the lung is blocked. It helps in relaxing the muscles of the air passages, thus widening it and making it easier to breathe.
Unibrez 150mcg Rotacap is used to prevent breathing problems due to asthma
Unibrez 150mcg Rotacap is used to prevent breathing problems due to asthma
Uses of Unibrez Rotacap
Benefits of Unibrez Rotacap
In Chronic obstructive pulmonary disease (COPD)
Unibrez 150mcg Rotacap helps the airways in your lungs stay open. It relaxes the muscles of these airways. This makes it easier for air to get in and out. It will relieve symptoms such as tightness in your chest, shortness of breath, wheezing and coughing and help you carry out your daily activities more easily. This medicine is safe and effective. It usually starts to work within a few minutes and the effects can last up to several hours. Do not stop using it unless you are advised to by your doctor.
Side effects of Unibrez Rotacap
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Unibrez
- Cough
- Oropharyngeal pain
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Headache
- Nausea
How to use Unibrez Rotacap
Rotacaps must not be swallowed. Check the label for directions before use. Place the capsule at the base of rotahaler, not in the mouthpiece. Twist the mouthpiece completely until your hear a click and breathe in deeply through the mouthpiece. Hold your breath for up to 10 seconds. If some powder remains in the rotahaler repeat the process.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Unibrez 150mcg Rotacap.
Pregnancy
CONSULT YOUR DOCTOR
Unibrez 150mcg Rotacap may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Unibrez 150mcg Rotacap is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Driving
No interaction found/established
Kidney
No interaction found/established
Liver
No interaction found/established
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- This medicine is for inhalation only. The tablet should not be swallowed.
- It does not work right away and should not be used to relieve sudden breathing problems.
- Take the first dose of this medicine under medical supervision as it may cause wheezing or tightening of the airways (bronchospasm) immediately after using.
- Dry mouth may occur as a side effect. Frequent mouth rinses, good oral hygiene, increased water intake and sugarless candy may help.
Fact Box
Chemical Class
Hydroxyquinolones Derivatives
Habit Forming
No
Therapeutic Class
RESPIRATORY
Action Class
Long acting β2-agonists
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Westfall TC, WestfallIn DP. Adrenergic Agonists and Antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 294.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 703.
- Indacaterol. 2011. [Accessed 01 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 01 Apr. 2019] (online) Available from:
Marketer details
Name: Cipla Ltd
Address: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013
Country of origin: India
Lab tests offered by us
Related/Popular tests
DISCONTINUED
We do not facilitate sale of this product at present